10-87952143-G-T
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000314.8(PTEN):c.518G>T(p.Arg173Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R173S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | MANE Select | c.518G>T | p.Arg173Leu | missense | Exon 6 of 9 | NP_000305.3 | ||
| PTEN | NM_001304717.5 | c.1037G>T | p.Arg346Leu | missense | Exon 7 of 10 | NP_001291646.4 | |||
| PTEN | NM_001304718.2 | c.-74G>T | 5_prime_UTR | Exon 6 of 9 | NP_001291647.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PTEN | ENST00000371953.8 | TSL:1 MANE Select | c.518G>T | p.Arg173Leu | missense | Exon 6 of 9 | ENSP00000361021.3 | ||
| PTEN | ENST00000693560.1 | c.1037G>T | p.Arg346Leu | missense | Exon 7 of 10 | ENSP00000509861.1 | |||
| PTEN | ENST00000700029.2 | c.518G>T | p.Arg173Leu | missense | Exon 6 of 10 | ENSP00000514759.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R173L variant (also known as c.518G>T), located in coding exon 6 of the PTEN gene, results from a G to T substitution at nucleotide position 518. The arginine at codon 173 is replaced by leucine, an amino acid with dissimilar properties. Two likely pathogenic alterations, p.R173C and p.R173P, have been described in the same codon (Hopman SM et al, Am. J. Med. Genet. A 2012 Jul; 158A(7):1719-23; Lachlan KL et al, J. Med. Genet. 2007 Sep; 44(9):579-85;(Kirches E, Neuropathol. Appl. Neurobiol. 2010 Feb; 36(1):86-9).. The p.R173L variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than 83000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Ovarian neoplasm Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at